Inhibition of Adipogenesis by Ghrelin

Por Zhang, Weizhen, Zhao, Lili, Lin, Theodore R., Chai, Biaoxin, Fan, Yongyi, Gantz, Ira, Mulholland, Michael W.
Publicado em 2004

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadeq...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Sato, Asako, Okuyama, Kotoba, O’Neill, Edward A., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Ther (2017)

A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Okuyama, Kotoba, O'Neill, Edward A., Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Obes Metab (2017)

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

Por Hauber, A. Brett, Tunceli, Kaan, Yang, Jui-Chen, Gantz, Ira, Brodovicz, Kimberly G., Alexander, Charles M., Davies, Michael J., Radican, Larry
Publicado no Diabetes Ther (2015)

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Por Gantz, Ira, Chen, Menghui, Suryawanshi, Shailaja, Ntabadde, Catherine, Shah, Sukrut, O’Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Lai, Eseng
Publicado no Cardiovasc Diabetol (2017)

Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist

Por Li, Xiujiang (Susie), Nielsen, Jace, Cirincione, Brenda, Li, Hankun, Addy, Carol, Wagner, John, Hartford, Alan, Erondu, Ngozi, Gantz, Ira, Morgan, Jerry, Stone, Julie
Publicado em 2010

Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibito...

Por Goldenberg, Ronald, Gantz, Ira, Andryuk, Paula J., O'Neill, Edward A., Kaufman, Keith D., Lai, Eseng, Wang, Yin Na, Suryawanshi, Shailaja, Engel, Samuel S.
Publicado no Diabetes Obes Metab (2017)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequ...

Por Lee, Seung-Hwan, Gantz, Ira, Round, Elizabeth, Latham, Melanie, O’Neill, Edward A., Ceesay, Paulette, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no BMC Endocr Disord (2017)

Interactions of Human Melanocortin 4 Receptor with Non Peptide and Peptide Agonists

Por Pogozheva, Irina D., Chai, Biao-Xin, Lomize, Andrei L., Fong, Tung M., Weinberg, David H., Nargund, Ravi P., Mulholland, Michael W., Gantz, Ira, Mosberg, Henry I.
Publicado em 2005

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes

Por Hauber, A Brett, Han, Steven, Yang, Jui-Chen, Gantz, Ira, Tunceli, Kaan, Gonzalez, Juan Marcos, Brodovicz, Kimberly, Alexander, Charles M, Davies, Michael, Iglay, Kristy, Zhang, Qiaoyi, Radican, Larry
Publicado em 2013